NCT00061360View on ClinicalTrials.gov

Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia

PHASE2CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

June 26, 2003

Primary Completion Date

February 15, 2006

Study Completion Date

September 8, 2015

Conditions
Severe Aplastic Anemia
Interventions
DRUG

ATG+Rapamune+cyclosporine

ATG+Rapamune+cyclosporine

DRUG

ATG+cyclosporine

ATG+cyclosporine

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00061360 - Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia | Biotech Hunter | Biotech Hunter